Описание: Chapter 1. Introduction.- Chapter 2. AAC for Individuals with Autism Spectrum Disorder: Assessment and Establishing Treatment Goals.- Chapter 3. The Use of Technology in the Treatment of Autism.- Chapter 4. Technology, Autism and Occupational Therapy.-Chapter 5. Collaborative Teaming: OT and SLP Co-Treatment of Autism Spectrum Disorder.- Chapter 6. Supporting the Writing Skills of Individuals with Autism Spectrum Disorder Through Assistive Technologies.- Chapter 7. Using Visual Organizers and Technology: Supporting Executive Function, Abstract Language Comprehension and Social Learning.- Chapter 8. Do as I'm Doing: Video Modeling and Autism.- Chapter 9. Tapping into Technical Talent: Using Technology to Facilitate Personal, Social and Vocational Skills in Youth with Autism Spectrum Disorder (ASD).- Chapter 10. Evidence-Based Instruction for Students with Autism Spectrum Disorder: Teach Town Basics.- Chapter 11. An Mobile Technology as a Prosthesis: Using Mobile Technology to Support Community Engagement and Independence.- Chapter 12. An Insider's Look at Technology and Autism.- Chapter 13. A Look Forward.
Описание: In the fall of 2009, Amy Lutz and her husband, Andy, struggled with one of the worst decisions parents could possibly face: whether they could safely keep their autistic ten-year-old son, Jonah, at home any longer. Multiple medication trials, a long procession of behavior modification strategies, and even an almost year-long hospitalization had all failed to control his violent rages. Desperate to stop the attacks that endangered family members, caregivers, and even Jonah himself, Amy and Andy decided to try the controversial procedure of electroconvulsive therapy or ECT. Over the last three years, Jonah has received 136 treatments. His aggression has greatly diminished, and for the first time Jonah, now fourteen, is moving to a less restricted school.
Each Day I Like It Better recounts the journeys of Jonah and seven other children and their families (interviewed by the author) in their quests for appropriate educational placements and therapeutic interventions. The author describes their varied, but mostly successful, experiences with ECT.
A survey of research on pediatric ECT is incorporated into the narrative, and a foreword by child psychiatrist Dirk Dhossche and ECT researcher and practitioner Charles Kellner explains how ECT works, the side effects patients may experience, and its current use in the treatment of autism, catatonia, and violent behavior in children.
Описание: In the fall of 2009, Amy Lutz and her husband, Andy, struggled with one of the worst decisions parents could possibly face: whether they could safely keep their autistic ten-year-old son, Jonah, at home any longer. Multiple medication trials, a long procession of behavior modification strategies, and even an almost year-long hospitalization had all failed to control his violent rages. Desperate to stop the attacks that endangered family members, caregivers, and even Jonah himself, Amy and Andy decided to try the controversial procedure of electroconvulsive therapy or ECT. Over the last three years, Jonah has received 136 treatments. His aggression has greatly diminished, and for the first time Jonah, now fourteen, is moving to a less restricted school.
Each Day I Like It Better recounts the journeys of Jonah and seven other children and their families (interviewed by the author) in their quests for appropriate educational placements and therapeutic interventions. The author describes their varied, but mostly successful, experiences with ECT.
A survey of research on pediatric ECT is incorporated into the narrative, and a foreword by child psychiatrist Dirk Dhossche and ECT researcher and practitioner Charles Kellner explains how ECT works, the side effects patients may experience, and its current use in the treatment of autism, catatonia, and violent behavior in children.
Описание: A practical guide to treating children suffering from early attachment trauma.
Автор: Stuart MacLeod; Suzanne Hill; Gideon Koren; Anders Название: Optimizing Treatment for Children in the Developing World ISBN: 3319380583 ISBN-13(EAN): 9783319380582 Издательство: Springer Рейтинг: Цена: 8384.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries.
Описание: Focused on central nervous system (CNS) drug discovery efforts, this book educates drug researchers about the blood-brain barrier (BBB) so they can affect important improvements in one of the most significant and most challenging areas of drug discovery.
Автор: Ronald Borchardt; Edward Kerns; Michael Hageman; D Название: Optimizing the "Drug-Like " Properties of Leads in Drug Discovery ISBN: 1493950479 ISBN-13(EAN): 9781493950478 Издательство: Springer Рейтинг: Цена: 27950.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, “drug-like” properties refer to the molecule’s physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
